Board of Directors

Board of Directors

  • Steve Aselage
    Chairman

    Mr. Aselage has more than 30 years of pharmaceutical and biotechnology experience, most recently serving as Chief Executive Officer of Travere Therapeutics (TVTX) (formerly Retrophin, Inc.) from 2014 to 2019. Previously, he was Executive Vice President and Chief Business Officer of BioMarin Pharmaceutical Inc. During his seven years with BioMarin, he built the commercial and […]

    VIEW MORE
  • Jason Amello
    Director

    Mr. Amello is the Chief Financial Officer of Saniona AB and has held that position since September 2020. From 2013 to 2020, he served as the Chief Financial Officer and Treasurer of Akebia Therapeutics, Inc. Prior to joining Akebia, Mr. Amello served as Executive Vice President, Chief Financial Officer, and Treasurer of ZIOPHARM Oncology, Inc., […]

    VIEW MORE
  • John M. Dunn
    Director

    Mr. Dunn has served as director since September 2017. Since 2019, Mr. Dunn has worked as a consultant in the life sciences industry. From November 2014 to April 2019, he served as General Counsel of Vital Therapies, Inc., a Nasdaq-listed biotherapeutic company. Prior to joining Vital Therapies, Mr. Dunn was a consultant from February 2012 […]

    VIEW MORE
  • Michelle Griffin
    Director

    Ms. Griffin has served as a director since September 2017. Ms. Griffin serves as a member of the Board of Directors and as Chair of the Audit Committee for publicly traded companies Chinook Therapeutics, Inc. since October 2020, Adaptive Biotechnologies Corporation since March 2019, and HTG Molecular Diagnostics, Inc. since August 2018. From 2013 to […]

    VIEW MORE
  • Chris Schelling
    Chief Executive Officer & Founder, Director

    Mr. Schelling has served as a director and as our President and Chief Executive Officer since September 2017. Mr. Schelling founded Acer in December 2013 and served as a director from that time until September 2017. From December 2013 to February 2016, he served as Acer’s Chief Operating Officer, and from February 2016 until 2017, […]

    VIEW MORE
QUICK
NAV